Ohio Public Employees Retirement System (OPERS)’s Harvard Bioscience HBIO Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-863	Closed	-$36K	–	1989
2023 Q1	$36K	Sell	863 -368	-30%	-$10.9K	﹤0.01%	1648
2022 Q4	$34K	Sell	1,231 -329	-21%	-$8.11K	﹤0.01%	1668
2022 Q3	$40K	Buy	+1,560	New	+$51.6K	﹤0.01%	1904
2021 Q1	–	Sell	-1,237	Closed	-$53K	–	1986
2020 Q4	$53K	Hold	1,237	–	–	﹤0.01%	1799
2020 Q3	$37K	Hold	1,237	–	–	﹤0.01%	1793
2020 Q2	$38K	Buy	+1,237	New	+$33.3K	﹤0.01%	1776

Other funds holding HBIO

272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s HBIO Position: Q2 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Harvard Bioscience (HBIO) in Q2 2023, closing a stake of 863 shares — an estimated $36K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in HBIO in Q2 2020 and held it in 6 quarters. The position peaked at $53K in Q4 2020. 100 funds tracked by Wall St. Rank hold HBIO as of Q2 2023.

Ohio Public Employees Retirement System (OPERS) reported no remaining Harvard Bioscience position as of Q2 2023 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 863 Harvard Bioscience shares in Q2 2023, an estimated $36K.
Ohio Public Employees Retirement System (OPERS) first reported a position in Harvard Bioscience in Q2 2020 and held it in 6 quarters.
Ohio Public Employees Retirement System (OPERS)'s Harvard Bioscience position peaked at $53K in Q4 2020.
100 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2023, filed 15 Aug 2023.